Domat/Ems, Switzerland

Thomas Wiedemann

This inventor holds 12 USPTO granted patents and 10 EPO patents. Top assignees: Ems-Patent Ag, Ems-Chemie Ag. Active years: 2020-2025.


% Patents Active = 100.0

 

Average Co-Inventor Count = 2.4

ph-index = 4

Forward Citations = 37(Granted Patents)


Location History:

  • Ems, CH (2022)
  • Domat/Ems, CH (2020 - 2024)

Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Journey of Thomas Wiedemann

Introduction: Thomas Wiedemann, a pioneering inventor hailing from Domat/Ems, Switzerland, has made significant contributions to the field of technology through his inventive spirit and dedication to innovation.

Latest Patents: Thomas Wiedemann's latest patents showcase his forward-thinking approach to problem-solving and his commitment to pushing the boundaries of technological advancements in various industries.

Career Highlights: With a career marked by groundbreaking inventions, Thomas Wiedemann has established himself as a leading figure in the world of innovation. His ability to transform ideas into tangible solutions has led to numerous successful ventures and patents that have revolutionized the way we approach challenges in today's fast-paced world.

Collaborations: Throughout his career, Thomas Wiedemann has collaborated with top industry experts, research institutions, and leading companies to bring his inventions to life. These collaborations have not only enhanced the quality of his work but have also opened up new avenues for innovation and growth.

Conclusion: In conclusion, Thomas Wiedemann's innovative spirit, coupled with his relentless drive to create, has solidified his position as a trailblazer in the world of technology. His contributions continue to inspire future generations of inventors and pave the way for a more innovative and technologically advanced future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…